
Eli Lilly's May Meltdown Is In History Books — Could June Seasonality Bring A Rebound?
Eli Lilly and Co. LLY is on track to close one of its worst months ever after slashing its full-year profit outlook despite beating first-quarter earnings estimates. But a glimmer of hope lies ahead, as June historically stands out as the drugmaker's …